[go: up one dir, main page]
Skip to main content
Springer Nature Link
Log in

Parkinsonian traits in amyotrophic lateral sclerosis (ALS): a prospective population-based study

  • Original Communication
  • Published:
Journal of Neurology Aims and scope Submit manuscript

Abstract

Background

Amyotrophic lateral sclerosis (ALS) is characterized by a spectrum of phenotypes, but only a few studies have addressed the presence of parkinsonian (PK) symptoms. The aim of our study was to investigate the occurrence of PK features in a prospective population-based cohort of ALS patients, determining their demographic, clinical, neuropsychological and genetic characteristics, and identifying their morphological and functional imaging correlates.

Methods

A consecutive series of ALS patients were enrolled and prospectively followed for 2 years. Patients were classified according to the presence (ALS-PK) or absence (ALS) of PK signs, and they underwent neuropsychological testing, genetic analysis for the main ALS and PD genes, brain MRI and 18F-FDG-PET. ALS-PK patients underwent 123I-ioflupane SPECT.

Results

Out of 114 eligible patients, 101 (64 men; mean age at onset 65.1 years) were recruited. Thirty-one patients (30.7%) were classified as ALS-PK. Compared to ALS patients, ALS-PK patients were more frequently male, but did not differ for any other clinical, demographic or neuropsychological factors. 123I-ioflupane SPECT was normal in all but two ALS-PK patients. At 18F-FDG-PET, ALS-PK patients showed a relative hypometabolism in left cerebellum and a relatively more preserved metabolism in right insula and frontal regions; MRI fractional anisotropy was reduced in the sagittal stratum and increased in the retrolenticular part of the internal capsule.

Conclusions

In our study, about 30% of ALS patients showed PK signs. Neuroimaging data indicate that PK signs are due to the involvement of brain circuitries other than classical nigrostriatal ones, strengthening the hypothesis of ALS as a complex multisystem disease.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Subscribe and save

Springer+ Basic
$34.99 /Month
  • Get 10 units per month
  • Download Article/Chapter or eBook
  • 1 Unit = 1 Article or 1 Chapter
  • Cancel anytime
Subscribe now

Buy Now

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2
Fig. 3
Fig. 4

Similar content being viewed by others

Abbreviations

ALS:

Amyotrophic lateral sclerosis

PD:

Parkinson’s disease

PARALS:

Piemonte and Valle d’Aosta Register for ALS

FTD:

Frontotemporal dementia

ALS-PK:

ALS patients with co-morbid parkinsonian disorder

References

  1. van Es MA, Hardiman O, Chio A, Al-Chalabi A, Pasterkamp RJ, Veldink JH, van den Berg LH (2017) Amyotrophic lateral sclerosis. Lancet 390(10107):2084–2098

    Article  PubMed  Google Scholar 

  2. Phukan J, Elamin M, Bede P, Jordan N, Gallagher L, Byrne S, Lynch C, Pender N, Hardiman O (2012) The syndrome of cognitive impairment in amyotrophic lateral sclerosis: a population-based study. J Neurol Neurosurg Psychiatry 83(1):102–108

    Article  PubMed  Google Scholar 

  3. Montuschi A, Iazzolino B, Calvo A, Moglia C, Lopiano L, Restagno G, Brunetti M, Ossola I, Lo Presti A, Cammarosano S et al (2015) Cognitive correlates in amyotrophic lateral sclerosis: a population-based study in Italy. J Neurol Neurosurg Psychiatry 86(2):168–173

    Article  PubMed  Google Scholar 

  4. Al-Chalabi A, Hardiman O, Kiernan MC, Chio A, Rix-Brooks B, van den Berg LH (2016) Amyotrophic lateral sclerosis: moving towards a new classification system. Lancet Neurol 15(11):1182–1194

    Article  PubMed  Google Scholar 

  5. Brait K, Fahn S, Schwarz GA (1973) Sporadic and familial parkinsonism and motor neuron disease. Neurology 23(9):990–1002

    Article  CAS  PubMed  Google Scholar 

  6. Pradat PF, Bruneteau G, Munerati E, Salachas F, Le Forestier N, Lacomblez L, Lenglet T, Meininger V (2009) Extrapyramidal stiffness in patients with amyotrophic lateral sclerosis. Mov Disord 24(14):2143–2148

    Article  PubMed  Google Scholar 

  7. Pupillo E, Bianchi E, Messina P, Chiveri L, Lunetta C, Corbo M, Filosto M, Lorusso L, Marin B, Mandrioli J et al (2015) Extrapyramidal and cognitive signs in amyotrophic lateral sclerosis: a population based cross-sectional study. Amyotroph Lateral Scler Frontotemporal Degener 16(5–6):324–330

    Article  PubMed  Google Scholar 

  8. Brooks BR, Miller RG, Swash M, Munsat TL (2000) World federation of neurology research group on motor neuron D: El Escorial revisited: revised criteria for the diagnosis of amyotrophic lateral sclerosis. Amyotroph Lateral Scler Other Motor Neuron Disord 1(5):293–299

    Article  CAS  PubMed  Google Scholar 

  9. Chio A, Calvo A, Moglia C, Mazzini L, Mora G (2011) group Ps: phenotypic heterogeneity of amyotrophic lateral sclerosis: a population based study. J Neurol Neurosurg Psychiatry 82(7):740–746

    Article  PubMed  Google Scholar 

  10. Postuma RB, Berg D, Stern M, Poewe W, Olanow CW, Oertel W, Obeso J, Marek K, Litvan I, Lang AE et al (2015) MDS clinical diagnostic criteria for Parkinson’s disease. Mov Disord 30(12):1591–1601

    Article  PubMed  Google Scholar 

  11. Ling H, Kara E, Bandopadhyay R, Hardy J, Holton J, Xiromerisiou G, Lees A, Houlden H, Revesz T (2013) TDP-43 pathology in a patient carrying G2019S LRRK2 mutation and a novel p.Q124E MAPT. Neurobiol Aging 34(12):2889 (e2885–2889)

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  12. Goetz CG, Tilley BC, Shaftman SR, Stebbins GT, Fahn S, Martinez-Martin P, Poewe W, Sampaio C, Stern MB, Dodel R et al (2008) Movement disorder society-sponsored revision of the Unified Parkinson’s Disease Rating Scale (MDS-UPDRS): scale presentation and clinimetric testing results. Mov Disord 23(15):2129–2170

    Article  PubMed  Google Scholar 

  13. Strong MJ, Grace GM, Freedman M, Lomen-Hoerth C, Woolley S, Goldstein LH, Murphy J, Shoesmith C, Rosenfeld J, Leigh PN et al (2009) Consensus criteria for the diagnosis of frontotemporal cognitive and behavioural syndromes in amyotrophic lateral sclerosis. Amyotroph Lateral Scler 10(3):131–146

    Article  PubMed  Google Scholar 

  14. Armstrong MJ, Litvan I, Lang AE, Bak TH, Bhatia KP, Borroni B, Boxer AL, Dickson DW, Grossman M, Hallett M et al (2013) Criteria for the diagnosis of corticobasal degeneration. Neurology 80(5):496–503

    Article  PubMed  PubMed Central  Google Scholar 

  15. Pinkhardt EH, Sperfeld AD, Gdynia HJ, Ludolph AC, Kassubek J (2009) The combination of dopa-responsive parkinsonian syndrome and motor neuron disease. Neurodegener Dis 6(3):95–101

    Article  CAS  PubMed  Google Scholar 

  16. Williams TL, Shaw PJ, Lowe J, Bates D, Ince PG (1995) Parkinsonism in motor neuron disease: case report and literature review. Acta Neuropathol 89(3):275–283

    Article  CAS  PubMed  Google Scholar 

  17. Desai J, Swash M (1999) Extrapyramidal involvement in amyotrophic lateral sclerosis: backward falls and retropulsion. J Neurol Neurosurg Psychiatry 67(2):214–216

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  18. Zoccolella S, Palagano G, Fraddosio A, Russo I, Ferrannini E, Serlenga L, Maggio F, Lamberti S, Iliceto G (2002) ALS-plus: 5 cases of concomitant amyotrophic lateral sclerosis and parkinsonism. Neurol Sci 23(Suppl 2):S123–S124

    Article  PubMed  Google Scholar 

  19. Manno C, Lipari A, Bono V, Taiello AC, La Bella V (2013) Sporadic Parkinson disease and amyotrophic lateral sclerosis complex (Brait-Fahn-Schwartz disease). J Neurol Sci 326(1–2):104–106

    Article  PubMed  Google Scholar 

  20. Belin J, Gordon PH, Guennoc AM, De Toffol B, Corcia P (2015) Brait-Fahn-Schwarz disease: the missing link between ALS and Parkinson’s disease. Amyotroph Lateral Scler Frontotemporal Degener 16(1–2):135–136

    Article  PubMed  Google Scholar 

  21. Gilbert RM, Fahn S, Mitsumoto H, Rowland LP (2010) Parkinsonism and motor neuron diseases: twenty-seven patients with diverse overlap syndromes. Mov Disord 25(12):1868–1875

    Article  PubMed  Google Scholar 

  22. Boeve BF, Boylan KB, Graff-Radford NR, DeJesus-Hernandez M, Knopman DS, Pedraza O, Vemuri P, Jones D, Lowe V, Murray ME et al (2012) Characterization of frontotemporal dementia and/or amyotrophic lateral sclerosis associated with the GGGGCC repeat expansion in C9ORF72. Brain 135(Pt 3):765–783

    Article  PubMed  PubMed Central  Google Scholar 

  23. Theuns J, Verstraeten A, Sleegers K, Wauters E, Gijselinck I, Smolders S, Crosiers D, Corsmit E, Elinck E, Sharma M et al (2014) Global investigation and meta-analysis of the C9orf72 (G4C2)n repeat in Parkinson disease. Neurology 83(21):1906–1913

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  24. Borasio GD, Linke R, Schwarz J, Schlamp V, Abel A, Mozley PD, Tatsch K (1998) Dopaminergic deficit in amyotrophic lateral sclerosis assessed with [I-123] IPT single photon emission computed tomography. J Neurol Neurosurg Psychiatry 65(2):263–265

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  25. Takahashi H, Snow BJ, Bhatt MH, Peppard R, Eisen A, Calne DB (1993) Evidence for a dopaminergic deficit in sporadic amyotrophic lateral sclerosis on positron emission scanning. Lancet 342(8878):1016–1018

    Article  CAS  PubMed  Google Scholar 

  26. Hideyama T, Momose T, Shimizu J, Tsuji S, Kwak S (2006) A positron emission tomography study on the role of nigral lesions in parkinsonism in patients with amyotrophic lateral sclerosis. Arch Neurol 63(12):1719–1722

    Article  PubMed  Google Scholar 

  27. Teune LK, Renken RJ, de Jong BM, Willemsen AT, van Osch MJ, Roerdink JB, Dierckx RA, Leenders KL (2014) Parkinson’s disease-related perfusion and glucose metabolic brain patterns identified with PCASL-MRI and FDG-PET imaging. NeuroImage Clinical 5:240–244

    Article  PubMed  PubMed Central  Google Scholar 

  28. Holtbernd F, Ma Y, Peng S, Schwartz F, Timmermann L, Kracht L, Fink GR, Tang CC, Eidelberg D, Eggers C (2015) Dopaminergic correlates of metabolic network activity in Parkinson’s disease. Hum Brain Mapp 36(9):3575–3585

    Article  PubMed  PubMed Central  Google Scholar 

  29. Teune LK, Bartels AL, de Jong BM, Willemsen AT, Eshuis SA, de Vries JJ, van Oostrom JC, Leenders KL (2010) Typical cerebral metabolic patterns in neurodegenerative brain diseases. Mov Disord 25(14):2395–2404

    Article  PubMed  Google Scholar 

  30. Zheng Z, Shemmassian S, Wijekoon C, Kim W, Bookheimer SY, Pouratian N (2014) DTI correlates of distinct cognitive impairments in Parkinson’s disease. Hum Brain Mapp 35(4):1325–1333

    Article  PubMed  Google Scholar 

  31. Worker A, Blain C, Jarosz J, Chaudhuri KR, Barker GJ, Williams SC, Brown RG, Leigh PN, Dell’Acqua F, Simmons A (2014) Diffusion tensor imaging of Parkinson’s disease, multiple system atrophy and progressive supranuclear palsy: a tract-based spatial statistics study. PLoS One 9(11):e112638

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  32. Kraus MF, Susmaras T, Caughlin BP, Walker CJ, Sweeney JA, Little DM (2007) White matter integrity and cognition in chronic traumatic brain injury: a diffusion tensor imaging study. Brain 130(Pt 10):2508–2519

    Article  PubMed  Google Scholar 

Download references

Acknowledgements

The Project has been supported by Italian Ministry of Health (Ricerca Finalizzata Giovani Ricercatori 2010; GR-2010-2320550, PI AndC); AndC thanks ‘Vialli e Mauro Foundation’; AntC thanks ‘Magnetto Foundation’. This study was supported by Ministero dell’Istruzione, dell’Università e della Ricerca—MIUR project “Dipartimenti di Eccellenza 2018–2022” to ‘Rita Levi Montalcini’ Department of Neuroscience.

Author information

Author notes

  1. Andrea Calvo, Adriano Chiò, Marco Pagani, Leonardo Lopiano, and Mario G. Rizzone equally contributed to the paper.

Authors and Affiliations

  1. Department of Neuroscience “Rita Levi Montalcini”, ALS Center, University of Turin, Via Cherasco 15, 1026, Turin, Italy

    Andrea Calvo, Adriano Chiò, Stefania Cammarosano, Cristina Moglia, Luca Solero, Umberto Manera, Maura Brunetti, Marco Barberis, Rosario Vasta, Barbara Iazzolino & Antonio Canosa

  2. Department of Neuroscience “Rita Levi Montalcini”, Movement Disorders Center, University of Turin, Turin, Italy

    Tiziana Martone, Carlo Alberto Artusi, Elisa Montanaro, Alberto Romagnolo, Leonardo Lopiano & Mario G. Rizzone

  3. Institute of Cognitive Sciences and Technologies, CNR, Rome, Italy

    Marco Pagani

  4. Department of Nuclear Medicine, Karolinska Hospital Stockholm, Solna, Sweden

    Marco Pagani

  5. Division of Function and Technology, Department of Clinical Science, Intervention and Technology, Karolinska Institutet, 141 86, Stockholm, Sweden

    Tie-Qiang Li

  6. Division of MR Physics, Department of Medical Radiation and Nuclear Medicine, Karolinska University Hospital, 141 86, Stockholm, Sweden

    Tie-Qiang Li

  7. Clinical Neurology, Department of Neuroscience (DINOGMI), University of Genoa and Polyclinic San Martino Hospital, Genoa, Italy

    Flavio Nobili

  8. Neurology Unit, Ospedali Riuniti di Rivoli, Rivoli, Italy

    Francesca Dematteis

  9. Nuclear Medicine Clinic, University of Turin, Turin, Italy

    Michele Balma & Giancarlo Castellano

  10. Positron Emission Tomography Centre IRMET S.p.A., Affidea, Turin, Italy

    Angelina Cistaro

  11. Neuroradiology Unit, AOU Città della Salute e della Scienza di Torino, Turin, Italy

    Giovanna Carrara & Consuelo Valentini

Authors
  1. Andrea Calvo
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Adriano Chiò
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Marco Pagani
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Stefania Cammarosano
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Francesca Dematteis
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Cristina Moglia
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. Luca Solero
    View author publications

    You can also search for this author in PubMed Google Scholar

  8. Umberto Manera
    View author publications

    You can also search for this author in PubMed Google Scholar

  9. Tiziana Martone
    View author publications

    You can also search for this author in PubMed Google Scholar

  10. Maura Brunetti
    View author publications

    You can also search for this author in PubMed Google Scholar

  11. Michele Balma
    View author publications

    You can also search for this author in PubMed Google Scholar

  12. Giancarlo Castellano
    View author publications

    You can also search for this author in PubMed Google Scholar

  13. Marco Barberis
    View author publications

    You can also search for this author in PubMed Google Scholar

  14. Angelina Cistaro
    View author publications

    You can also search for this author in PubMed Google Scholar

  15. Carlo Alberto Artusi
    View author publications

    You can also search for this author in PubMed Google Scholar

  16. Rosario Vasta
    View author publications

    You can also search for this author in PubMed Google Scholar

  17. Elisa Montanaro
    View author publications

    You can also search for this author in PubMed Google Scholar

  18. Alberto Romagnolo
    View author publications

    You can also search for this author in PubMed Google Scholar

  19. Barbara Iazzolino
    View author publications

    You can also search for this author in PubMed Google Scholar

  20. Antonio Canosa
    View author publications

    You can also search for this author in PubMed Google Scholar

  21. Giovanna Carrara
    View author publications

    You can also search for this author in PubMed Google Scholar

  22. Consuelo Valentini
    View author publications

    You can also search for this author in PubMed Google Scholar

  23. Tie-Qiang Li
    View author publications

    You can also search for this author in PubMed Google Scholar

  24. Flavio Nobili
    View author publications

    You can also search for this author in PubMed Google Scholar

  25. Leonardo Lopiano
    View author publications

    You can also search for this author in PubMed Google Scholar

  26. Mario G. Rizzone
    View author publications

    You can also search for this author in PubMed Google Scholar

Contributions

AC, AC, LL and MGR contributed to the fund raising, literature search, figures, study design, data collection, data analysis, data interpretation, writing, and revision of the manuscript. AC, AC, SC, FD, UM, CM, AR, BI and EM contributed to the data collection, data analysis, and revision of the manuscript. LS, UM, CAA and AC contributed to writing, data analysis and revision of the manuscript. MP, QT and FN contributed to data analysis, data interpretation, and revision of the manuscript. TM, MB, GC, MB, AC, GC and CV contributed to data collection, data analysis, data interpretation, and revision of the manuscript.

Corresponding author

Correspondence to Andrea Calvo.

Ethics declarations

Conflicts of interest

Andrea Calvo reports no disclosure. Adriano Chiò reports personal fees from Biogen Idec, Cytokinetics, Mitsubishi Tanabe, and Neuraltus, outside the submitted work. Marco Pagani reports no disclosure. Stefania Cammarosano reports no disclosure. Francesca Dematteis reports no disclosure. Cristina Moglia reports no disclosure. Luca Solero reports no disclosure. Umberto Manera reports no disclosure. Tiziana Martone reports no disclosure. Maura Brunetti reports no disclosure. Michele Balma reports no disclosure. Giancarlo Castellano reports no disclosure. Marco Barberis reports no disclosure. Angelina Cistaro reports no disclosure. Carlo Alberto Artusi reports no disclosure. Elisa Montanaro reports no disclosure. Alberto Romagnolo reports no disclosure. Barbara Iazzolino reports no disclosure. Antonio Canosa reports no disclosure. Giovanna Carrara reports no disclosure. Consuelo Valentini reports no disclosure. Tie-Qiang Li reports no disclosure. Flavio Nobili reports no disclosure. Leonardo Lopiano reports no disclosure. Mario G. Rizzone reports no disclosure.

Electronic supplementary material

Below is the link to the electronic supplementary material.

Supplementary material 1 (DOCX 25 kb)

Supplementary material 2 (DOCX 33 kb)

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Calvo, A., Chiò, A., Pagani, M. et al. Parkinsonian traits in amyotrophic lateral sclerosis (ALS): a prospective population-based study. J Neurol 266, 1633–1642 (2019). https://doi.org/10.1007/s00415-019-09305-0

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00415-019-09305-0

Keywords